Pfizer, BioNTech Fight To Invalidate CureVac COVID Patents
Pharma giants Pfizer and BioNTech urged a London court on Wednesday to invalidate COVID-19 vaccine patents owned by a German company, saying the rival vaccine patent should be nixed because it...To view the full article, register now.
Already a subscriber? Click here to view full article